These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Tokuhira M; Hosaka S; Volin MV; Haines GK; Katschke KJ; Kim S; Koch AE Arthritis Rheum; 2000 May; 43(5):1122-33. PubMed ID: 10817567 [TBL] [Abstract][Full Text] [Related]
3. Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. Kitani A; Nakashima N; Izumihara T; Inagaki M; Baoui X; Yu S; Matsuda T; Matsuyama T J Immunol; 1998 Nov; 161(9):4931-8. PubMed ID: 9794428 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4. Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179 [TBL] [Abstract][Full Text] [Related]
5. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions. Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055 [TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5. Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651 [TBL] [Abstract][Full Text] [Related]
7. Soluble form of vascular cell adhesion molecule 1 induces migration and proliferation of vascular smooth muscle cells. Lee HM; Kim HJ; Won KJ; Choi WS; Park SH; Song H; Park PJ; Park TK; Lee CK; Kim B J Vasc Res; 2008; 45(3):259-68. PubMed ID: 18182825 [TBL] [Abstract][Full Text] [Related]
8. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Kato H; Ueki S; Kamada R; Kihara J; Yamauchi Y; Suzuki T; Takeda M; Itoga M; Chihara M; Ito W; Kayaba H; Chihara J Int Arch Allergy Immunol; 2011; 155(4):335-44. PubMed ID: 21346363 [TBL] [Abstract][Full Text] [Related]
9. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Wong CK; Cheung PF; Lam CW Eur J Immunol; 2007 Aug; 37(8):2337-48. PubMed ID: 17634954 [TBL] [Abstract][Full Text] [Related]
10. Role of the Mac-1 and VLA-4 integrins, and concomitant Th2-cytokine production, in nitric oxide modulated eosinophil migration from bone marrow to lungs in allergic mice. Pelaquini EH; Guimarães Lde A; Benetti LR; Fernandes LG; Tamashiro WM; Conran N; Ferreira HH Int Immunopharmacol; 2011 Feb; 11(2):204-11. PubMed ID: 21111080 [TBL] [Abstract][Full Text] [Related]
11. Superoxide activates very late antigen-4 on an eosinophil cell line and increases cellular binding to vascular cell adhesion molecule-1. Chuang KP; Tsai WS; Wang YJ; Shieh CC Eur J Immunol; 2003 Mar; 33(3):645-55. PubMed ID: 12616485 [TBL] [Abstract][Full Text] [Related]
12. 2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challenge. El-Shazly AE; Henket M; Lefebvre PP; Louis R Int J Immunopathol Pharmacol; 2011; 24(4):949-60. PubMed ID: 22230401 [TBL] [Abstract][Full Text] [Related]
13. Syndecan-4-dependent migration of human eosinophils. Feistritzer C; Kaneider NC; Sturn DH; Wiedermann CJ Clin Exp Allergy; 2004 May; 34(5):696-703. PubMed ID: 15144459 [TBL] [Abstract][Full Text] [Related]
14. Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase. Schratl P; Sturm EM; Royer JF; Sturm GJ; Lippe IT; Peskar BA; Heinemann A Eur J Immunol; 2006 Sep; 36(9):2401-9. PubMed ID: 16906532 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Schizandrae Fructus on eotaxin secretion in A549 human epithelial cells and eosinophil migration. Oh BG; Lee H; Kim Y; Shin M; Hong M; Jung SK; Kim J; Bae H Phytomedicine; 2009 Sep; 16(9):814-22. PubMed ID: 19324539 [TBL] [Abstract][Full Text] [Related]
16. Monocyte migration: a novel effect and signaling pathways of catestatin. Egger M; Beer AG; Theurl M; Schgoer W; Hotter B; Tatarczyk T; Vasiljevic D; Frauscher S; Marksteiner J; Patsch JR; Schratzberger P; Djanani AM; Mahata SK; Kirchmair R Eur J Pharmacol; 2008 Nov; 598(1-3):104-11. PubMed ID: 18834877 [TBL] [Abstract][Full Text] [Related]
17. Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils. Svensson L; Redvall E; Johnsson M; Stenfeldt AL; Dahlgren C; Wennerås C J Leukoc Biol; 2009 Aug; 86(2):327-36. PubMed ID: 19414538 [TBL] [Abstract][Full Text] [Related]
18. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Wu P; Mitchell S; Walsh GM Clin Exp Allergy; 2005 Aug; 35(8):1073-9. PubMed ID: 16120090 [TBL] [Abstract][Full Text] [Related]
19. The synthetic PPARgamma agonist troglitazone inhibits eotaxin-enhanced eosinophil adhesion to ICAM-1-coated plates. Hirasawa H; Chiba T; Ueki S; Kamada Y; Ito W; Takeda M; Fujita M; Kato H; Kayaba H; Chihara J Int Arch Allergy Immunol; 2008; 146 Suppl 1():11-5. PubMed ID: 18504400 [TBL] [Abstract][Full Text] [Related]
20. Crucial implication of protein kinase C (PKC)-delta, PKC-zeta, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils. Langlois A; Chouinard F; Flamand N; Ferland C; Rola-Pleszczynski M; Laviolette M J Leukoc Biol; 2009 Apr; 85(4):656-63. PubMed ID: 19164129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]